1. Home
  2. JOB vs CLRB Comparison

JOB vs CLRB Comparison

Compare JOB & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

N/A

Current Price

$0.23

Market Cap

23.9M

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

N/A

Current Price

$1.83

Market Cap

24.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JOB
CLRB
Founded
1893
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
24.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
JOB
CLRB
Price
$0.23
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 195.3K
52.1K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $96,504,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$1.80
52 Week High
$0.28
$6.52

Technical Indicators

Market Signals
Indicator
JOB
CLRB
Relative Strength Index (RSI) 44.05 20.45
Support Level $0.22 N/A
Resistance Level $0.27 $2.70
Average True Range (ATR) 0.01 0.13
MACD -0.00 -0.05
Stochastic Oscillator 18.96 6.15

Price Performance

Historical Comparison
JOB
CLRB

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: